Stay updated on Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedThe study document revision was updated to v3.6.6 with two new update dates (2026-08-24 and 2026-08-05) and a revised file size of 1.86MB, reflecting changes to the attached document and its metadata.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays Revision: v3.6.5 in place of Revision: v3.6.4. This indicates a software/markup update to the study page.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a minor update to the page template or documentation. This update does not affect the study content or data.SummaryDifference0.0%

- Check62 days agoChange DetectedThe revision label now reads v3.6.3 where it previously showed v3.6.2. This update reflects a small metadata version change and does not modify the study details.SummaryDifference0.0%

- Check69 days agoChange DetectedNew revision tag v3.6.2 has been added, replacing the previous v3.6.0. This reflects a minor update to the page’s underlying documentation/software version without changing the study content or how the page functions.SummaryDifference0.0%

- Check83 days agoChange DetectedThe study page now states that recruitment has ended and includes new sections to help readers understand and join the study. The Intervention/Treatment heading has been standardized.SummaryDifference0.3%

Stay in the know with updates to Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.